Third and last post of the day.
Needsomestock:
You just created a hypothetical situation and then blamed them for not being able to execute.
Management did not have capital. They are a development stage company. Their stem cell biz got crushed by Covid19 (clinics shutting down and not ordering stem cells.) Their other businesses are all development stage.
Of course had they not been working on developing these other businesses, then they would have had the money to develop antibody test kits faster this year - maybe. But that's like reading today's newspaper to buy stock yesterday morning. And were it not for the other businesses, would they have been able to raise the capital that they burned through?
Their flexibility to develop the anti-body biz over the past few months was/is awesome.
Management have put themselves in an incredible position - and now they have to execute and I believe that they will.
Yes, if they had $10 mil in the bank, they could have ramped up without Wellgistics -- but they didn't.
For the record, I agree with you -- I cannot stand how they managed their financial affairs last year. That was REALLY BAD and unacceptable. But that's the past. I am looking at the present and future.
As unimpressed as I am with last year's performance, I am very impressed with them this year. If some of this year's initiatives come together in June/July (as I expect will happen) I will be very happy and will make a lot of money. And management will deserve all of the credit.
At the end of the day, I actually think that we are mostly in agreement.
News 
Market Data 
Discover 
